PROCEPT BioRobotics (PRCT) Accounts Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Accounts Payables data on file, last reported at $18.9 million in Q1 2026.

• Quarterly Accounts Payables rose 27.14% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (up 27.14% YoY) and the FY2025 annual result came in at $17.3 million, up 72.3% from the prior year.
• Accounts Payables rose to $18.9 million in Q1 2026 per PRCT's latest filing, from $17.3 million in the prior quarter.
• Across five years, Accounts Payables topped out at $18.9 million in Q1 2026 and bottomed at $2.6 million in Q1 2022.
• The 5-year median for Accounts Payables is $10.3 million (2023), against an average of $11.1 million.
• The widest annual swing landed in 2022, when Accounts Payables jumped 362.84%; it then decreased 26.31% in 2025.
• Tracing PRCT's Accounts Payables over 5 years: stood at $9.4 million in 2022, then soared by 43.74% to $13.5 million in 2023, then declined by 25.68% to $10.0 million in 2024, then soared by 72.3% to $17.3 million in 2025, then grew by 9.06% to $18.9 million in 2026.
• Per Business Quant, the three latest PRCT Accounts Payables figures stand at $18.9 million (Q1 2026), $17.3 million (Q4 2025), and $11.1 million (Q3 2025).

Peer Comparison